Atsuko Kasajima Selected Research

Atsuko Kasajima Research Topics

Disease

25	Neoplasms (Cancer) 02/2022 - 11/2010
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 10/2013
5	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2004
4	Carcinoma (Carcinomatosis) 10/2021 - 10/2004
4	Adenocarcinoma 10/2021 - 10/2012
3	Breast Neoplasms (Breast Cancer) 04/2013 - 03/2006
2	Neuroendocrine Carcinoma 10/2021 - 01/2018
2	Insulinoma 05/2021 - 01/2020
2	Small Cell Carcinoma 02/2021 - 02/2019
2	Lymphatic Metastasis 01/2020 - 11/2010
2	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 03/2014
2	Carcinogenesis 04/2013 - 01/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2012 - 12/2010
2	Stomach Neoplasms (Stomach Cancer) 01/2012 - 11/2010
1	COVID-19 03/2022
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 02/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2022
1	Microsatellite Instability 09/2021
1	Hypoglycemia (Reactive Hypoglycemia) 05/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021
1	Colitis 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2020
1	Pheochromocytoma 01/2020
1	Paraganglioma (Paragangliomas) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Adenoma (Adenomas) 06/2015
1	Hyperplasia 05/2015
1	Stomach Ulcer (Gastric Ulcer) 05/2015
1	Gastrinoma 05/2015
1	Primitive Neuroectodermal Tumors (PNET) 01/2015
1	Lung Diseases (Lung Disease) 07/2014
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2014
1	Angiomyolipoma 03/2014
1	Intellectual Disability (Idiocy) 10/2013
1	Thalassemia 10/2013
1	Disease Progression 04/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2016 - 09/2011
5	SynaptophysinIBA 02/2022 - 12/2016
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2021 - 05/2015
5	Hormones (Hormone)IBA 11/2020 - 03/2006
4	Chromogranin AIBA 02/2022 - 12/2016
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 11/2010
3	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2015
3	Oxidoreductases (Dehydrogenase)IBA 06/2015 - 04/2014
2	Keratins (Keratin)IBA 02/2022 - 01/2020
2	somatostatin receptor 2IBA 12/2021 - 01/2018
2	lanreotide (Somatuline)FDA Link 11/2021 - 05/2021
2	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2021 - 01/2018
2	Biological ProductsIBA 10/2021 - 02/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2014
2	Annexin A1IBA 01/2021 - 01/2020
2	Progesterone FDA LinkGeneric 01/2018 - 01/2015
2	Estrogens (Estrogen)FDA Link 07/2014 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2014 - 09/2011
2	MicroRNAs (MicroRNA)IBA 10/2012 - 11/2010
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 12/2021
1	Everolimus FDA Link 11/2021
1	RNA (Ribonucleic Acid)IBA 09/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ProinsulinIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2018
1	Carcinoembryonic AntigenIBA 01/2018
1	CyclinsIBA 01/2018
1	NAD (NADH)IBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2016
1	Calcitonin Gene-Related PeptideIBA 12/2016
1	Macrophage Colony-Stimulating FactorIBA 04/2016
1	Fetal Proteins (Fetoprotein)IBA 12/2015
1	Vitamin K FDA Link 12/2015
1	Tumor Biomarkers (Tumor Markers)IBA 12/2015
1	3 beta-hydroxysteroid dehydrogenase type IIIBA 06/2015
1	AldosteroneIBA 06/2015
1	Histidine (L-Histidine)FDA Link 05/2015
1	GastrinsIBA 05/2015
1	Cyclin D1IBA 01/2015
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2014
1	Aromatase (CYP19)IBA 07/2014
1	Dehydroepiandrosterone (DHEA)IBA 04/2014
1	SulfotransferasesIBA 04/2014
1	inhibin-alpha subunitIBA 04/2014
1	SteroidsIBA 04/2014
1	Testosterone (Sustanon)FDA Link 04/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2014
1	Histones (Histone)IBA 04/2013
1	IsoenzymesIBA 04/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2013

Therapy/Procedure

7	Therapeutics 09/2021 - 09/2011
1	Personal Protective Equipment 03/2022
1	Molecular Targeted Therapy 09/2021
1	Conservative Treatment 01/2021
1	Esophagectomy 02/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Prostatectomy (Retropubic Prostatectomy) 01/2015